Prediction of Ki-67 expression in hepatocellular carcinoma: a dual-center study based on T2-Weighted imaging habitat analysis
Abstract
Background. Limited research has applied habitat imaging to evaluate the association between T2-weighted magnetic resonance imaging (T2WI-MRI) features and Ki-67 expression in hepatocellular carcinoma(HCC). This study aimed to link T2WI habitat-derived parameters to Ki-67 status and aggressiveness in HCC.
Patients and methods. This dual-center retrospective study, enrolled patients with pathologically confirmed HCC undergoing preoperative MRI (2020-2024). Using Ki-67 index cutoff (20%). Tumor habitat partitioning was performed using k-means clustering (k=5), followed by extraction of both habitat-specific radiomic features and conventional whole-tumor features. Feature selection was conducted using least absolute shrinkage and selection operator (LASSO) regression with 10-fold cross-validation. Three predictive models were constructed with the ExtraTrees algorithm: a habitat model, a radiomics model, and a clinical model. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), DeLong test, and decision curve analysis (DCA).
Results. T2WI-based habitat imaging enables a noninvasive assessment of intratumoral heterogeneity, significantly improving the prediction of Ki-67 expression status in HCC. This approach may provide a promising imaging biomarker for molecular subtyping and support personalized preoperative treatment strategies.
Conclusions. T2WI habitat imaging enables improved Ki-67 prediction, supporting informed therapeutic decisions in HCC.
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Xiaojun Zheng, Lihong Huang, Mengjie Huang, Bin Yu, Shiji Qin, Deyou Huang

This work is licensed under a Creative Commons Attribution 4.0 International License.
License to Publish
Please read the terms of this agreement, print, initial page 1, sign page 3, scan and send the document as one file attached to an e-mail to gsersa@onko-i.si